Literature DB >> 591444

Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B.

M Konishi, K Saito, K Numata, T Tsuno, K Asama.   

Abstract

The structures of tallysomycins A and B, two major components of a new antitumor antibiotic complex, have been determined. They are glycopeptide antibiotics structurally related to bleomycin: four amino acid moieties and a disaccharide fragment which are the constituents of bleomycin molecule are also present in the tallysomycins. Tallysomycins A and B contain two new amino acids and a unique amino sugar, 4-amino-4,6-dideoxy-L-talose, which have not been hitherto found in the phleomycin-bleomycin group of antibiotics. In addition tallysomycin A has an additional amino acid, L-beta-lysine, and thus a longer peptide chain than bleomycin or tallysomycin B. Tallysomycins A and B have the same terminal amine moiety, spermidine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591444     DOI: 10.7164/antibiotics.30.789

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Crystal Structure of the Zorbamycin-Binding Protein ZbmA, the Primary Self-Resistance Element in Streptomyces flavoviridis ATCC21892.

Authors:  Jeffrey D Rudolf; Lance Bigelow; Changsoo Chang; Marianne E Cuff; Jeremy R Lohman; Chin-Yuan Chang; Ming Ma; Dong Yang; Shonda Clancy; Gyorgy Babnigg; Andrzej Joachimiak; George N Phillips; Ben Shen
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

3.  Functional characterization of tlmK unveiling unstable carbinolamide intermediates in the tallysomycin biosynthetic pathway.

Authors:  Liyan Wang; Meifeng Tao; Evelyn Wendt-Pienkoski; Ute Galm; Jane M Coughlin; Ben Shen
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

4.  Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.

Authors:  C K Mirabelli; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  The biosynthetic gene cluster of zorbamycin, a member of the bleomycin family of antitumor antibiotics, from Streptomyces flavoviridis ATCC 21892.

Authors:  Ute Galm; Evelyn Wendt-Pienkowski; Liyan Wang; Nicholas P George; Tae-Jin Oh; Fan Yi; Meifeng Tao; Jane M Coughlin; Ben Shen
Journal:  Mol Biosyst       Date:  2008-11-12

6.  Multicomponent approach to the synthesis of oxidized amides through nitrile hydrozirconation.

Authors:  Shuangyi Wan; Michael E Green; Jung-Hyun Park; Paul E Floreancig
Journal:  Org Lett       Date:  2007-11-17       Impact factor: 6.005

7.  Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.

Authors:  C K Mirabelli; C H Huang; A W Prestayko; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic.

Authors:  M Greenstein; J L Speth; W M Maiese
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

9.  BlmB and TlmB provide resistance to the bleomycin family of antitumor antibiotics by N-acetylating metal-free bleomycin, tallysomycin, phleomycin, and zorbamycin.

Authors:  Jane M Coughlin; Jeffrey D Rudolf; Evelyn Wendt-Pienkowski; Liyan Wang; Claudia Unsin; Ute Galm; Dong Yang; Meifeng Tao; Ben Shen
Journal:  Biochemistry       Date:  2014-10-23       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.